Phosphorylated ERK is a potential predictor of sensitivity to sorafenib when treating hepatocellular carcinoma: evidence from an in vitro study
Zhe Zhang, Xiaoping Zhou, Hu-jia Shen, De-xing Wang, Yan‐hong Wang
BMC Medicine